HEADER ANTIMICROBIAL PROTEIN 17-JUL-21 7P6T TITLE CRYSTAL STRUCTURE OF THE FIMH-BINDING DECOY MODULE OF HUMAN TITLE 2 GLYCOPROTEIN 2 (GP2) (CRYSTAL FORM III) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM ALPHA OF PANCREATIC SECRETORY GRANULE MEMBRANE COMPND 3 MAJOR GLYCOPROTEIN GP2; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PANCREATIC ZYMOGEN GRANULE MEMBRANE PROTEIN GP-2,ZAP75; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GP2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: EXPI293F GNTI-; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PLJ6 KEYWDS EXTRACELLULAR MATRIX, GLYCOPROTEIN, N-GLYCAN, STRUCTURAL PROTEIN, KEYWDS 2 DECOY MODULE, D10C DOMAIN, D8C SEQUENCE, PANCREAS, INTESTINE, KEYWDS 3 MUCOSAL IMMUNITY, FIMH, ALPHAFOLD, ANTIMICROBIAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.STSIAPANAVA,K.TUNYASUVUNAKOOL,J.JUMPER,D.DE SANCTIS,L.JOVINE REVDAT 3 30-MAR-22 7P6T 1 JRNL REVDAT 2 23-MAR-22 7P6T 1 JRNL REVDAT 1 16-MAR-22 7P6T 0 JRNL AUTH A.STSIAPANAVA,C.XU,S.NISHIO,L.HAN,N.YAMAKAWA,M.CARRONI, JRNL AUTH 2 K.TUNYASUVUNAKOOL,J.JUMPER,D.DE SANCTIS,B.WU,L.JOVINE JRNL TITL STRUCTURE OF THE DECOY MODULE OF HUMAN GLYCOPROTEIN 2 AND JRNL TITL 2 UROMODULIN AND ITS INTERACTION WITH BACTERIAL ADHESIN FIMH. JRNL REF NAT.STRUCT.MOL.BIOL. V. 29 190 2022 JRNL REFN ESSN 1545-9985 JRNL PMID 35273390 JRNL DOI 10.1038/S41594-022-00729-3 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.A.RONZIO,K.E.KRONQUIST,D.S.LEWIS,R.J.MACDONALD, REMARK 1 AUTH 2 S.H.MOHRLOK,J.J.O'DONNELL JR. REMARK 1 TITL GLYCOPROTEIN SYNTHESIS IN THE ADULT RAT PANCREAS. IV. REMARK 1 TITL 2 SUBCELLULAR DISTRIBUTION OF MEMBRANE GLYCOPROTEINS. REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V. 508 65 1978 REMARK 1 REFN ISSN 0006-3002 REMARK 1 PMID 629968 REMARK 1 DOI 10.1016/0005-2736(78)90189-X REMARK 1 REFERENCE 2 REMARK 1 AUTH S.FUKUOKA REMARK 1 TITL MOLECULAR CLONING AND SEQUENCES OF CDNAS ENCODING ALPHA REMARK 1 TITL 2 (LARGE) AND BETA (SMALL) ISOFORMS OF HUMAN PANCREATIC REMARK 1 TITL 3 ZYMOGEN GRANULE MEMBRANE-ASSOCIATED PROTEIN GP2. REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1491 376 2000 REMARK 1 REFN ISSN 0006-3002 REMARK 1 PMID 10760606 REMARK 1 DOI 10.1016/S0167-4781(00)00057-9 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.KOBAYASHI,K.YANAGIHARA,K.ISHIGURO,S.FUKUOKA REMARK 1 TITL GP2/THP GENE FAMILY OF SELF-BINDING, GPI-ANCHORED PROTEINS REMARK 1 TITL 2 FORMS A CLUSTER AT CHROMOSOME 7F1 REGION IN MOUSE GENOME. REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 322 659 2004 REMARK 1 REFN ISSN 0006-291X REMARK 1 PMID 15325280 REMARK 1 DOI 10.1016/J.BBRC.2004.07.197 REMARK 1 REFERENCE 4 REMARK 1 AUTH H.YANG,C.WU,S.ZHAO,J.GUO REMARK 1 TITL IDENTIFICATION AND CHARACTERIZATION OF D8C, A NOVEL DOMAIN REMARK 1 TITL 2 PRESENT IN LIVER-SPECIFIC LZP, UROMODULIN AND GLYCOPROTEIN REMARK 1 TITL 3 2, MUTATED IN FAMILIAL JUVENILE HYPERURICAEMIC NEPHROPATHY. REMARK 1 REF FEBS LETT. V. 578 236 2004 REMARK 1 REFN ISSN 0014-5793 REMARK 1 PMID 15589826 REMARK 1 DOI 10.1016/J.FEBSLET.2004.10.092 REMARK 1 REFERENCE 5 REMARK 1 AUTH S.YU,A.W.LOWE REMARK 1 TITL THE PANCREATIC ZYMOGEN GRANULE MEMBRANE PROTEIN, GP2, BINDS REMARK 1 TITL 2 ESCHERICHIA COLI TYPE 1 FIMBRIAE. REMARK 1 REF BMC GASTROENTEROL V. 9 58 2009 REMARK 1 REFN ISSN 1471-230X REMARK 1 PMID 19627615 REMARK 1 DOI 10.1186/1471-230X-9-58 REMARK 1 REFERENCE 6 REMARK 1 AUTH K.HASE,K.KAWANO,T.NOCHI,G.S.PONTES,S.FUKUDA,M.EBISAWA, REMARK 1 AUTH 2 K.KADOKURA,T.TOBE,Y.FUJIMURA,S.KAWANO,A.YABASHI,S.WAGURI, REMARK 1 AUTH 3 G.NAKATO,S.KIMURA,T.MURAKAMI,M.IIMURA,K.HAMURA,S.FUKUOKA, REMARK 1 AUTH 4 A.W.LOWE,K.ITOH,H.KIYONO,H.OHNO REMARK 1 TITL UPTAKE THROUGH GLYCOPROTEIN 2 OF FIMH(+) BACTERIA BY M CELLS REMARK 1 TITL 2 INITIATES MUCOSAL IMMUNE RESPONSE. REMARK 1 REF NATURE V. 462 226 2009 REMARK 1 REFN ESSN 1476-4687 REMARK 1 PMID 19907495 REMARK 1 DOI 10.1038/NATURE08529 REMARK 1 REFERENCE 7 REMARK 1 AUTH D.ROGGENBUCK,G.HAUSDORF,L.MARTINEZ-GAMBOA,D.REINHOLD, REMARK 1 AUTH 2 T.BUTTNER,P.R.JUNGBLUT,T.PORSTMANN,M.W.LAASS,J.HENKER, REMARK 1 AUTH 3 C.BUNING,E.FEIST,K.CONRAD REMARK 1 TITL IDENTIFICATION OF GP2, THE MAJOR ZYMOGEN GRANULE MEMBRANE REMARK 1 TITL 2 GLYCOPROTEIN, AS THE AUTOANTIGEN OF PANCREATIC ANTIBODIES IN REMARK 1 TITL 3 CROHN'S DISEASE. REMARK 1 REF GUT V. 58 1620 2009 REMARK 1 REFN ISSN 1468-3288 REMARK 1 PMID 19549613 REMARK 1 DOI 10.1136/GUT.2008.162495 REMARK 1 REFERENCE 8 REMARK 1 AUTH B.BONACI-NIKOLIC,M.SPURAN,S.ANDREJEVIC,M.NIKOLIC REMARK 1 TITL AUTOANTIBODIES TO GP2, THE MAJOR ZYMOGEN GRANULE MEMBRANE REMARK 1 TITL 2 GLYCOPROTEIN, IN PATIENTS WITH GLUTEN-SENSITIVE ENTEROPATHY: REMARK 1 TITL 3 A POSSIBLE SEROLOGICAL TRAP. REMARK 1 REF CLIN.CHIM.ACTA V. 413 822 2012 REMARK 1 REFN ISSN 0009-8981 REMARK 1 PMID 22269156 REMARK 1 DOI 10.1016/J.CCA.2012.01.005 REMARK 1 REFERENCE 9 REMARK 1 AUTH J.JUMPER,R.EVANS,A.PRITZEL,T.GREEN,M.FIGURNOV,O.RONNEBERGER, REMARK 1 AUTH 2 K.TUNYASUVUNAKOOL,R.BATES,A.ZIDEK,A.POTAPENKO,A.BRIDGLAND, REMARK 1 AUTH 3 A.W.SENIOR,C.MEYER,K.KAVUKCUOGLU,S.A.A.KOHL,P.KOHLI, REMARK 1 AUTH 4 A.J.BALLARD,D.HASSABIS,A.COWIE,B.ROMERA-PAREDES,S.NIKOLOV, REMARK 1 AUTH 5 R.JAIN,J.ADLER,T.BACK,S.PETERSEN,D.REIMAN,E.CLANCY, REMARK 1 AUTH 6 M.ZIELINSKI,M.STEINEGGER,M.PACHOLSKA,T.BERGHAMMER, REMARK 1 AUTH 7 S.BODENSTEIN,D.SILVER,O.VINYALS REMARK 1 TITL HIGHLY ACCURATE PROTEIN STRUCTURE PREDICTION WITH ALPHAFOLD REMARK 1 REF NATURE 2021 REMARK 1 REFN ESSN 1476-4687 REMARK 1 PMID 34265844 REMARK 1 DOI 10.1038/S41586-021-03819-2 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV-4282 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.97 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 32510 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.200 REMARK 3 FREE R VALUE TEST SET COUNT : 2017 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.9700 - 3.3700 1.00 2303 152 0.1471 0.1790 REMARK 3 2 3.3700 - 2.6800 1.00 2246 148 0.1565 0.1943 REMARK 3 3 2.6800 - 2.3400 0.97 2164 143 0.1645 0.1793 REMARK 3 4 2.3400 - 2.1300 0.95 2101 138 0.1630 0.1816 REMARK 3 5 2.1300 - 1.9700 0.98 2176 145 0.1627 0.2077 REMARK 3 6 1.9700 - 1.8600 0.98 2162 143 0.1974 0.2329 REMARK 3 7 1.8600 - 1.7600 0.99 2162 144 0.2101 0.2441 REMARK 3 8 1.7600 - 1.6900 0.99 2217 145 0.2595 0.3051 REMARK 3 9 1.6900 - 1.6200 0.99 2182 145 0.2979 0.2906 REMARK 3 10 1.6200 - 1.5700 1.00 2185 145 0.3491 0.3459 REMARK 3 11 1.5700 - 1.5200 0.99 2172 144 0.4020 0.4052 REMARK 3 12 1.5200 - 1.4700 0.99 2169 145 0.4386 0.4636 REMARK 3 13 1.4700 - 1.4400 0.99 2191 145 0.4940 0.5323 REMARK 3 14 1.4300 - 1.4000 0.95 2063 135 0.5385 0.5023 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.229 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.316 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 1183 REMARK 3 ANGLE : 0.675 1611 REMARK 3 CHIRALITY : 0.069 169 REMARK 3 PLANARITY : 0.009 203 REMARK 3 DIHEDRAL : 12.253 422 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7P6T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1292117106. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAY-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96770 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS FEB 5, 2021 BUILT=20210322 REMARK 200 DATA SCALING SOFTWARE : XSCALE FEB 5, 2021 REMARK 200 BUILT=20210322 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32721 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 28.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 3.37900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: REFINED MODEL OF CRYSTAL FORM II OF THE SAME REMARK 200 PROTEIN (PDB D_1292117105) REMARK 200 REMARK 200 REMARK: PLATE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% (W/V) PEG 20K, 25% (W/V) 1,1,1 REMARK 280 -TRIS(HYDROXYMETHYL) PROPANE, 0.1 M MOPSO/BIS-TRIS PH 6.5, 1% (W/ REMARK 280 V) NDSB 195, 0.01 M SPERMINE, 0.01 M SPERMIDINE, 0.01 M 1,4- REMARK 280 DIAMINOBUTANE, 0.01 M DL-ORNITHINE, 20 MM NA-HEPES PH 7.5, 150 REMARK 280 MM NACL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.07500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 16.83000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.07500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 16.83000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 29 REMARK 465 GLN A 30 REMARK 465 ARG A 31 REMARK 465 GLY A 32 REMARK 465 TYR A 33 REMARK 465 GLY A 34 REMARK 465 ASN A 35 REMARK 465 PRO A 36 REMARK 465 ILE A 37 REMARK 465 GLU A 38 REMARK 465 ALA A 39 REMARK 465 SER A 40 REMARK 465 SER A 41 REMARK 465 TYR A 42 REMARK 465 GLY A 43 REMARK 465 HIS A 182 REMARK 465 HIS A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 465 HIS A 188 REMARK 465 HIS A 189 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 65 77.81 -156.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7P6R RELATED DB: PDB REMARK 900 CRYSTAL FORM I OF THE SAME PROTEIN REMARK 900 RELATED ID: 7P6S RELATED DB: PDB REMARK 900 CRYSTAL FORM II OF THE SAME PROTEIN DBREF 7P6T A 29 181 UNP P55259 GP2_HUMAN 29 181 SEQADV 7P6T HIS A 182 UNP P55259 EXPRESSION TAG SEQADV 7P6T HIS A 183 UNP P55259 EXPRESSION TAG SEQADV 7P6T HIS A 184 UNP P55259 EXPRESSION TAG SEQADV 7P6T HIS A 185 UNP P55259 EXPRESSION TAG SEQADV 7P6T HIS A 186 UNP P55259 EXPRESSION TAG SEQADV 7P6T HIS A 187 UNP P55259 EXPRESSION TAG SEQADV 7P6T HIS A 188 UNP P55259 EXPRESSION TAG SEQADV 7P6T HIS A 189 UNP P55259 EXPRESSION TAG SEQRES 1 A 161 VAL GLN ARG GLY TYR GLY ASN PRO ILE GLU ALA SER SER SEQRES 2 A 161 TYR GLY LEU ASP LEU ASP CYS GLY ALA PRO GLY THR PRO SEQRES 3 A 161 GLU ALA HIS VAL CYS PHE ASP PRO CYS GLN ASN TYR THR SEQRES 4 A 161 LEU LEU ASP GLU PRO PHE ARG SER THR GLU ASN SER ALA SEQRES 5 A 161 GLY SER GLN GLY CYS ASP LYS ASN MET SER GLY TRP TYR SEQRES 6 A 161 ARG PHE VAL GLY GLU GLY GLY VAL ARG MET SER GLU THR SEQRES 7 A 161 CYS VAL GLN VAL HIS ARG CYS GLN THR ASP ALA PRO MET SEQRES 8 A 161 TRP LEU ASN GLY THR HIS PRO ALA LEU GLY ASP GLY ILE SEQRES 9 A 161 THR ASN HIS THR ALA CYS ALA HIS TRP SER GLY ASN CYS SEQRES 10 A 161 CYS PHE TRP LYS THR GLU VAL LEU VAL LYS ALA CYS PRO SEQRES 11 A 161 GLY GLY TYR HIS VAL TYR ARG LEU GLU GLY THR PRO TRP SEQRES 12 A 161 CYS ASN LEU ARG TYR CYS THR ASP PRO SER HIS HIS HIS SEQRES 13 A 161 HIS HIS HIS HIS HIS HET NAG A 201 27 HET NAG A 202 27 HET NAG A 203 27 HET 9D2 A 204 23 HET 9D2 A 205 23 HET 9D2 A 206 23 HET 9D2 A 207 23 HET 9D2 A 208 23 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 9D2 2-ETHYL-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 5 9D2 5(C6 H14 O3) FORMUL 10 HOH *134(H2 O) HELIX 1 AA1 ASP A 61 ASN A 65 5 5 HELIX 2 AA2 GLU A 71 SER A 75 5 5 SHEET 1 AA1 7 THR A 67 LEU A 69 0 SHEET 2 AA1 7 TRP A 92 PHE A 95 1 O TRP A 92 N THR A 67 SHEET 3 AA1 7 TYR A 161 ARG A 165 -1 O TYR A 164 N TYR A 93 SHEET 4 AA1 7 ASN A 144 CYS A 157 -1 N CYS A 157 O TYR A 161 SHEET 5 AA1 7 THR A 133 TRP A 141 -1 N ALA A 137 O THR A 150 SHEET 6 AA1 7 ALA A 117 LEU A 121 -1 N TRP A 120 O CYS A 138 SHEET 7 AA1 7 LEU A 174 TYR A 176 1 O ARG A 175 N MET A 119 SSBOND 1 CYS A 48 CYS A 59 1555 1555 2.03 SSBOND 2 CYS A 63 CYS A 157 1555 1555 2.06 SSBOND 3 CYS A 85 CYS A 172 1555 1555 2.07 SSBOND 4 CYS A 107 CYS A 145 1555 1555 2.05 SSBOND 5 CYS A 113 CYS A 177 1555 1555 2.03 SSBOND 6 CYS A 138 CYS A 146 1555 1555 2.05 LINK ND2 ASN A 65 C1 NAG A 201 1555 1555 1.43 LINK ND2 ASN A 122 C1 NAG A 202 1555 1555 1.44 LINK ND2 ASN A 134 C1 NAG A 203 1555 1555 1.44 CISPEP 1 CYS A 172 ASN A 173 0 5.70 CRYST1 90.150 33.660 59.630 90.00 111.84 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011093 0.000000 0.004445 0.00000 SCALE2 0.000000 0.029709 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018067 0.00000